DexCom Operating Income 2010-2024 | DXCM

DexCom annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • DexCom operating income for the quarter ending September 30, 2024 was $0.152B, a 26.03% decline year-over-year.
  • DexCom operating income for the twelve months ending September 30, 2024 was $628M, a 24.06% increase year-over-year.
  • DexCom annual operating income for 2023 was $0.598B, a 52.79% increase from 2022.
  • DexCom annual operating income for 2022 was $0.391B, a 47.18% increase from 2021.
  • DexCom annual operating income for 2021 was $0.266B, a 11.25% decline from 2020.
DexCom Annual Operating Income
(Millions of US $)
2023 $598
2022 $391
2021 $266
2020 $300
2019 $142
2018 $-186
2017 $-43
2016 $-64
2015 $-57
2014 $-22
2013 $-29
2012 $-56
2011 $-45
2010 $-45
2009 $-46
DexCom Quarterly Operating Income
(Millions of US $)
2024-09-30 $152
2024-06-30 $158
2024-03-31 $101
2023-12-31 $217
2023-09-30 $206
2023-06-30 $128
2023-03-31 $47
2022-12-31 $125
2022-09-30 $148
2022-06-30 $77
2022-03-31 $41
2021-12-31 $1
2021-09-30 $118
2021-06-30 $101
2021-03-31 $46
2020-12-31 $104
2020-09-30 $94
2020-06-30 $68
2020-03-31 $34
2019-12-31 $102
2019-09-30 $56
2019-06-30 $-1
2019-03-31 $-14
2018-12-31 $-165
2018-09-30 $14
2018-06-30 $-5
2018-03-31 $-31
2017-12-31 $12
2017-09-30 $-1
2017-06-30 $-14
2017-03-31 $-40
2016-12-31 $-6
2016-09-30 $-19
2016-06-30 $-20
2016-03-31 $-19
2015-12-31 $2
2015-09-30 $-42
2015-06-30 $-4
2015-03-31 $-13
2014-12-31 $2
2014-09-30 $-5
2014-06-30 $-6
2014-03-31 $-12
2013-12-31 $-2
2013-09-30 $-6
2013-06-30 $-10
2013-03-31 $-11
2012-12-31 $-8
2012-09-30 $-17
2012-06-30 $-15
2012-03-31 $-15
2011-12-31 $-12
2011-09-30 $-13
2011-06-30 $-7
2011-03-31 $-12
2010-12-31 $-10
2010-09-30 $-13
2010-06-30 $-11
2010-03-31 $-11
2009-12-31 $-9
2009-09-30 $-12
2009-06-30 $-13
2009-03-31 $-11
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $30.463B $3.622B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $202.584B 24.71
Intuitive Surgical (ISRG) United States $193.049B 100.93
Alcon (ALC) Switzerland $43.825B 29.32
Edwards Lifesciences (EW) United States $42.082B 26.72
IQVIA Holdings (IQV) United States $36.452B 20.08
IDEXX Laboratories (IDXX) United States $34.535B 40.67
Waters (WAT) United States $22.843B 33.78
STERIS (STE) Ireland $21.623B 24.89
SONOVA HOLDING (SONVY) Switzerland $20.352B 0.00
Hologic (HOLX) United States $18.042B 19.49
Sysmex ADR (SSMXY) Japan $13.304B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $12.922B 13.27
Globus Medical (GMED) United States $11.657B 29.52
Penumbra (PEN) United States $9.369B 91.77
Masimo (MASI) United States $9.238B 44.70
Teleflex (TFX) United States $8.957B 14.28
Glaukos (GKOS) United States $7.920B 0.00
PROCEPT BioRobotics (PRCT) United States $4.988B 0.00
Integer Holdings (ITGR) United States $4.713B 26.71
Veracyte (VCYT) United States $3.329B 99.88
Inari Medical (NARI) United States $3.040B 0.00
TransMedics (TMDX) United States $2.910B 92.25
LivaNova (LIVN) United Kingdom $2.851B 16.46
Nihon Kohden (NHNKY) Japan $2.276B 17.29
Elekta AB (EKTAY) Sweden $2.261B 20.33
Tandem Diabetes Care (TNDM) United States $2.012B 0.00
Integra LifeSciences Holdings (IART) United States $1.897B 9.91
RxSight (RXST) United States $1.889B 0.00
Alphatec Holdings (ATEC) United States $1.486B 0.00
Pulse Biosciences (PLSE) United States $1.316B 0.00
Artivion (AORT) United States $1.237B 82.00
OPKO Health (OPK) United States $1.051B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.881B 14.97
Paragon 28 (FNA) United States $0.863B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.746B 0.00
IRadimed (IRMD) United States $0.683B 36.94
Mesa Laboratories (MLAB) United States $0.636B 15.00
OrthoPediatrics (KIDS) United States $0.629B 0.00
AxoGen (AXGN) United States $0.612B 0.00
SiBone (SIBN) United States $0.569B 0.00
Treace Medical Concepts (TMCI) United States $0.531B 0.00
Pacific Biosciences Of California (PACB) United States $0.523B 0.00
Semler Scientific (SMLR) United States $0.473B 27.82
Tactile Systems Technology (TCMD) United States $0.469B 25.38
Delcath Systems (DCTH) United States $0.380B 0.00
CVRx (CVRX) United States $0.372B 0.00
ClearPoint Neuro (CLPT) United States $0.341B 0.00
NeuroPace (NPCE) United States $0.316B 0.00
AngioDynamics (ANGO) United States $0.282B 0.00
Inogen (INGN) United States $0.231B 0.00
Accuray (ARAY) United States $0.224B 0.00
Sight Sciences (SGHT) United States $0.203B 0.00
Alpha Tau Medical (DRTS) Israel $0.196B 0.00
KORU Medical Systems (KRMD) United States $0.182B 0.00
Nevro (NVRO) United States $0.172B 0.00
Atossa Genetics (ATOS) United States $0.164B 0.00
Sensus Healthcare (SRTS) United States $0.139B 14.93
Spectral Diagnostics (EDTXF) Canada $0.116B 0.00
908 Devices (MASS) United States $0.095B 0.00
EDAP TMS S.A (EDAP) France $0.091B 0.00
LENSAR (LNSR) United States $0.087B 0.00
Vicarious Surgical (RBOT) United States $0.083B 0.00
WORK Medical Technology Group (WOK) China $0.079B 0.00
InspireMD (NSPR) Israel $0.077B 0.00
Hyperfine (HYPR) United States $0.074B 0.00
Covalon Technologies (CVALF) Canada $0.072B 0.00
Monogram Orthopaedics (MGRM) United States $0.069B 0.00
Lucid Diagnostics (LUCD) United States $0.059B 0.00
EnVVeno Medical (NVNO) United States $0.055B 0.00
Envoy Medical (COCH) United States $0.046B 0.00
Rapid Micro Biosystems (RPID) United States $0.045B 0.00
Accelerate Diagnostics (AXDX) United States $0.042B 0.00
Adagio Medical Holdings (ADGM) United States $0.039B 0.00
Spectral AI (MDAI) United States $0.036B 0.00
Biosig Technologies (BSGM) United States $0.031B 0.00
Precision Optics (POCI) United States $0.031B 0.00
Neuronetics (STIM) United States $0.030B 0.00
DarioHealth (DRIO) United States $0.027B 0.00
NexGel (NXGL) United States $0.022B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Baird Medical Investment Holdings (BDMD) $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.015B 0.00
T2 Biosystems (TTOO) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
Autonomix Medical (AMIX) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00